Candidates for ablation for symptomatic atrial fibrillation who have morbid obesity should be considered for bariatric surgery prior to ablation, a new study suggests.
Pro football retirees are at least five times more likely to have atrial fibrillation than age- and race-matched male controls from the general population, finds a new cross-sectional study.
A new study of over 400 patients with left ventricular assist devices adds to the mixed evidence on atrial arrhythmias in this population and provides the first systematic look at the effects of rhythm control.
Our electrophysiologists share their approach to deciding between ablation and medical management along with a wealth of insights for care before and after the ablation procedure.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Debate around findings of the multicenter CABANA study of ablation versus drug therapy for atrial fibrillation shouldn’t distract from why patients seek ablation in the first place: symptom relief.
Our funded projects include a study of interactions among genomics, aging and metabolism and a clinical trial of metformin and lifestyle modifications for reducing AF burden.
As the use of LVADs for destination therapy grows, a new study offers the first guidance on whether aggressive treatment for atrial arrhythmias makes a difference in this setting.
A new study identified genes and genetic variations associated with 12 loci linked to risk for atrial fibrillation. The result is a genome-wide catalog to facilitate follow-on investigations.
Dr. Oussama Wazni suspects more patients with AF could benefit from early catheter ablation. So he’s leading two multicenter trials to see if his suspicions pan out.
A study shows that the first FDA-approved smartwatch healthcare accessory can effectively identify atrial fibrillation, especially with physician overview. But incorporating it into practice won’t be simple.